Search in:

Baylor University Medical Center Proceedings

The peer-reviewed journal of Baylor Scott & White Health

Volume 34, 2021 - Issue 1

Submit an article Journal homepage

179

Views

CrossRef citations to date

Altmetric

Original Research

Utility of oxcarbazepine in the treatment of childhood and adolescent psychiatric symptoms

Kyle MorrowDepartment of Psychiatry, Baylor Scott & White Health, Central Texas Division, and College of Medicine, Texas A&M University Health Science Center, Temple, Texas

, MD,

Keith A. YoungDepartment of Psychiatry, Baylor Scott & White Health, Central Texas Division, and College of Medicine, Texas A&M University Health Science Center, Temple, Texas

, PhD,

Shawn SpencerDepartment of Psychiatry, Baylor Scott & White Health, Central Texas Division, and College of Medicine, Texas A&M University Health Science Center, Temple, Texas

, DO,

Edgar Samuel MedinaDepartment of Psychiatry, Baylor Scott & White Health, Central Texas Division, and College of Medicine, Texas A&M University Health Science Center, Temple, Texas

, MD,

Michaela A. MarzialeDepartment of Psychiatry, Baylor Scott & White Health, Central Texas Division, and College of Medicine, Texas A&M University Health Science Center, Temple, Texas

, MD,

Alejandro SanchezDepartment of Psychiatry, Baylor Scott & White Health, Central Texas Division, and College of Medicine, Texas A&M University Health Science Center, Temple, Texas

, MD candidate &

James A. BourgeoisDepartment of Psychiatry, Baylor Scott & White Health, Central Texas Division, and College of Medicine, Texas A&M University Health Science Center, Temple, TexasCorrespondence[email protected]

, OD, MD show all

Pages 34-39 | Received 28 Jul 2020, Accepted 17 Sep 2020, Published online: 06 Oct 2020

Cite this article
https://doi.org/10.1080/08998280.2020.1826259
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

McAuley JW, Biederman TS, Smith JC, et al. Newer therapies in the drug treatment of epilepsy. Ann Pharmacother. 2002;36(1):119–128. doi:https://doi.org/10.1345/aph.10417.
PubMed Web of Science ®Google Scholar
Campos MS, Ayres LR, Morelo MR, et al. Efficacy and tolerability of antiepileptic drugs in patients with focal epilepsy: systematic review and network meta-analyses. Pharmacother. 2016;36(12):1255–1271. doi:https://doi.org/10.1002/phar.1855.
PubMed Web of Science ®Google Scholar
Nevitt SJ, Sudell M, Weston J, et al. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev. 2017;12:CD011412. doi:https://doi.org/10.1002/14651858.CD011412.pub3.
PubMedGoogle Scholar
Moavero R, Pisani LR, Pisani F, et al. Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy. Expert Opin Drug Saf. 2018;17(10):1015–1028. doi:https://doi.org/10.1080/14740338.2018.1518427.
PubMed Web of Science ®Google Scholar
Xu J, Shi X, Qiu Y, et al. Association between HLA-A*3201 allele and oxcarbazepine-induced cutaneous adverse reactions in Eastern Han Chinese population. Seizure. 2019;65:25–30. doi:https://doi.org/10.1016/j.seizure.2018.12.011.
PubMed Web of Science ®Google Scholar
Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Epilepsy Curr. 2018;18(4):260–268. doi:https://doi.org/10.5698/1535-7597.18.4.260.
PubMed Web of Science ®Google Scholar
Davids E, Kis B, Specka M, et al. A pilot clinical trial of oxcarbazepine in adults with attention-deficit disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1003–1038.
Web of Science ®Google Scholar
Kaufman KR, Gerner R. Adjunctive oxcarbazepine in comorbid anxiety and affective disorder with hyponatremic seizure: case analysis and literature review. Epilepsy Behav. 2003;4(6):766–770. doi:https://doi.org/10.1016/j.yebeh.2003.08.007.
PubMed Web of Science ®Google Scholar
Berigan T. Oxcarbazepine treatment of posttraumatic stress disorder. Can J Psychiatry. 2002;47(10):973–974. doi:https://doi.org/10.1177/070674370204701014.
PubMed Web of Science ®Google Scholar
Malek-Ahmadi P, Hanretta AT. Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder. Ann Pharmacother. 2004;38(11):1852–1854. doi:https://doi.org/10.1345/aph.1D442.
PubMed Web of Science ®Google Scholar
Gitlin M, Frye MA. Maintenance therapies in bipolar disorders. Bipolar Disord. 2012;14:51–65. doi:https://doi.org/10.1111/j.1399-5618.2012.00992.x.
PubMed Web of Science ®Google Scholar
Belli H, Ural C, Akbudak M. Borderline personality disorder: bipolarity, mood stabilizers and atypical antipsychotics in treatment. J Clin Med Res. 2012;4(5):301–308. doi:https://doi.org/10.4021/jocmr1042w.
PubMedGoogle Scholar
Eatmon CV, Daniel JS. Should you use an anticonvulsant to treat impulsivity and aggression? Curr Psychiatry. 2014; 13:49–51.
Google Scholar
Liu X, Carney PR, Bussing R, Segal R, Cottler LB, Winterstein AG. Trends in antiepileptic drug use in children and adolescents with epilepsy. Pediatr Neurol. 2017;74:32–40. doi:https://doi.org/10.1016/j.pediatrneurol.2017.05.016.
PubMed Web of Science ®Google Scholar
Besag F, Aldenkamp A, Caplan R, Dunn DW, Gobbi G, Sillanpää M. Psychiatric and behavioural disorders in children with epilepsy (ILAE Task Force Report): adverse cognitive and behavioural effects of antiepileptic drugs in children. Epileptic Disord. 2016;18(S1):1–86. doi:https://doi.org/10.1684/epd.2016.0817.
PubMedGoogle Scholar
Wei SH, Liu CC, Fan PC. A comparison of the efficacy and tolerability of oxcarbazepine oral suspension between infants and children with epilepsy: a retrospective chart review at a single medical center in Taiwan. Pediatr Drugs. 2014;16(1):83–89. doi:https://doi.org/10.1007/s40272-013-0049-x.
PubMed Web of Science ®Google Scholar
Verrotti A, Moavero R, Panzarino G, Di Paolantonio C, Rizzo R, Curatolo P. The challenge of pharmacotherapy in children and adolescents with epilepsy-ADHD comorbidity. Clin Drug Invest. 2018; 38(1):1–8. doi:https://doi.org/10.1007/s40261-017-0585-1.
PubMed Web of Science ®Google Scholar
Birmaher B, Brent D, Bernet W, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1503–1526. doi:https://doi.org/10.1097/chi.0b013e318145ae1c.
PubMed Web of Science ®Google Scholar
Steiner H, Remsing L. Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(1):126–141. doi:https://doi.org/10.1097/01.chi.0000246060.62706.af.
PubMed Web of Science ®Google Scholar
Volkmar F, Siegel M, Woodbury-Smith M, King B, McCracken J, State M. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2014;53(2):237–257. doi:https://doi.org/10.1016/j.jaac.2013.10.013.
PubMed Web of Science ®Google Scholar
Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(3):213–235. doi:https://doi.org/10.1097/00004583-200503000-00006.
PubMed Web of Science ®Google Scholar
Wagner KD, Kowatch RA, Emslie GJ, et al. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry. 2006;163(7):1179–1186. doi:https://doi.org/10.1176/ajp.2006.163.7.1179.
PubMed Web of Science ®Google Scholar
Douglas JF, Sanders KB, Benneyworth MH, et al. Brief report: retrospective case series of oxcarbazepine for irritability/agitation symptoms in autism spectrum disorder. J Autism Dev Disord. 2013;43(5):1243–1247. doi:https://doi.org/10.1007/s10803-012-1661-2.
PubMed Web of Science ®Google Scholar
Kapetanovic S. Oxcarbazepine in youths with autistic disorder and significant disruptive behaviors. Am J Psychiatry. 2007;164(5):832–833. doi:https://doi.org/10.1176/ajp.2007.164.5.832.
PubMed Web of Science ®Google Scholar
Coleman DM, Adams JB, Anderson AL, et al. Rating of the effectiveness of 26 psychiatric and seizure medications for autism spectrum disorder: results of a national survey. J Child Adolesc Psychopharmacol. 2019;29(2):107–123. doi:https://doi.org/10.1089/cap.2018.0121.
PubMed Web of Science ®Google Scholar
Brophy S, Kennedy J, Fernandez-Gutierrez F, et al. Characteristics of children prescribed antipsychotics: analysis of routinely collected data. J Child Adolesc Psychopharmacol. 2018;28(3):180–191. doi:https://doi.org/10.1089/cap.2017.0003.
PubMed Web of Science ®Google Scholar
Toren P, Ratner S, Laor N, et al. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents. Drug Saf. 2004;27(14):1135–1156. doi:https://doi.org/10.2165/00002018-200427140-00005.
PubMed Web of Science ®Google Scholar
Caccia S. Safety and pharmacokinetics of atypical antipsychotics in children and adolescents. Paediatr Drugs. 2013;15(3):217–233. doi:https://doi.org/10.1007/s40272-013-0024-6.
PubMed Web of Science ®Google Scholar
Barker MK, Sable CM, Montgomery SE, et al. Diet and cardiometabolic side effects in children treated with second-generation antipsychotics. Clin Nutr Espen. 2018; 23:205–211. doi:https://doi.org/10.1016/j.clnesp.2017.09.013.
PubMed Web of Science ®Google Scholar
Sjo CP, Stenstrøm AD, Bojesen AB, et al. Development of metabolic syndrome in drug-naive adolescents after 12 months of second-generation antipsychotic treatment. J Child Adolesc Psychopharmacol. 2017;27(10):884–891. doi:https://doi.org/10.1089/cap.2016.0171.
PubMed Web of Science ®Google Scholar
Scahill L, Jeon S, Boorin SJ, et al. Weight gain and metabolic consequences of risperidone in young children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2016;55(5):415–423. doi:https://doi.org/10.1016/j.jaac.2016.02.016.
PubMed Web of Science ®Google Scholar
Burghardt KJ, Seyoum B, Mallisho A, et al. Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies. Prog Neuropsychopharmacol Biol Psychiatry. 2018; 83:55–63. doi:https://doi.org/10.1016/j.pnpbp.2018.01.004.
PubMed Web of Science ®Google Scholar
Loy JH, Merry SN, Hetrick SE, et al. Atypical antipsychotics for disruptive behaviour disorders in children and youths. Cochrane Database Syst Rev. 2017;8:CD008559. doi:https://doi.org/10.1002/14651858.CD008559.pub2.
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Utility of oxcarbazepine in the treatment of childhood and adolescent psychiatric symptoms

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Utility of oxcarbazepine in the treatment of childhood and adolescent psychiatric symptoms

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date